Skip to main content
Caplight Logo









Cosomil, Inc.

Cosomil, Inc.

Private
TokyoHealthcare & Life Scienceshttps://cosomil.com/

Last Round

Series A

Extension

Feb 6, 2026

Total Funding Raised

$3.31M

Company Overview

Cosomil, Inc. is a biotechnology company that develops high-precision liquid biopsy diagnostic technologies for the early detection of cancer and drug development support.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

liquid biopsysingle-molecule enzyme activity-based protein profilingSEAPearly cancer detectionbiotech startupprecision medicinedrug discoverybiomarker discoverydiagnostic platformoncology diagnosticscontract researchmicrofluidicsnext-gen diagnosticsdeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cosomil, Inc. Comparables

Compare Cosomil, Inc. with similar companies based on industry and business-model similarity.

Cosomil, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MiRTeL Co., Ltd.
69%
Freenome
68%
HaploX
67%

Cosomil, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionFeb 6, 2026
GrantMar 22, 2024
Early FundingNov 29, 2023
Pre SeedApr 1, 2022

Key People

Founding team and executive leadership

Yu Kagami

CEO

Executive Team

Cosomil, Inc. Investors

Notable investors and investment history

Cosomil, Inc. investors
InvestorRounds
New Energy and Industrial Technology Development OrganizationGrant
ANRI株式会社Series A Extension, Early Funding
Delight VenturesSeries A Extension
Coral CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2024

    $3.3M grant from New Energy and Industrial Technology Development Organization.

Cosomil, Inc. Filings

Explore SEC and related filing metadata, where available.

Cosomil, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cosomil, Inc.'s valuation, stock price, and market status.

Is Cosomil, Inc. a public or private company?

Cosomil, Inc. is a private company.

What is the current stock price of Cosomil, Inc.?

Cosomil, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Cosomil, Inc. worth (valuation)?

Valuation information for Cosomil, Inc. is not publicly available.

Can I buy Cosomil, Inc. stock?

Cosomil, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cosomil, Inc.'s last funding round?

Cosomil, Inc.'s most recent funding round was Series A Extension on February 6, 2026.

Who are the main investors in Cosomil, Inc.?

Key investors in Cosomil, Inc. include Delight Ventures.

Will Cosomil, Inc. IPO soon?

No public IPO plans have been announced for Cosomil, Inc..

How can I track Cosomil, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cosomil, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range3
Year Founded2022
Last FundingFeb 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?